
Aethlon Medical, Inc.
- Jurisdiction
United States - LEI
54930036LMXCIW3XG337 - ISIN
US00808Y4061 (AEMD )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
3
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
2
/ 7
Profile
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. Read full profile
Fundamentals
- Net revenue
€0.00 - Gross margin
0.0% - EBIT
€706.76K - EBIT margin
0.0% - Net income
-€10.73M - Net margin
0.0%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Earnings Calls
Earnings Calls
Latest earnings call: August 13, 2025 (Q1 2026)